Coegin Pharma AB (NGM:COEGIN)

Market Cap	63.19M -64.4%
Revenue (ttm)	433.00K
Net Income	-21.71M
EPS	-0.87
Shares Out	28.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,621
Open	n/a
Previous Close	2.170
Day's Range	n/a
52-Week Range	2.170 - 7.300
Beta	0.93
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 19, 2026

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, develops and commercializes cosmetic technologies for hair and skin in Sweden. Its flagship product is Follicopeptide, a patented, clinically developed peptide technology targeting hair thinning; and NPP-4, a cosmetic peptide product designed to enhance skin tone without UV exposure or chemicals. The company also develops FOL026, a peptide drug candidate for the treatment of myocardial infarction; AVX420, a drug candidate for the treatment of leukemia; and AVX001, a drug candidate for the topical treat...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 3
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: COEGIN

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 20, 2026

Data Sources Report a data error